Candriam SCA’s Genomic Health, Inc. GHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
Sell
-30,765
Closed -$1.78M 832
2019
Q2
$1.78M Buy
30,765
+3,400
+12% +$197K 0.02% 535
2019
Q1
$1.92M Buy
27,365
+9,616
+54% +$674K 0.02% 508
2018
Q4
$1.14M Buy
17,749
+749
+4% +$48.2K 0.02% 563
2018
Q3
$1.19M Sell
17,000
-23,000
-58% -$1.62M 0.02% 591
2018
Q2
$2.02M Sell
40,000
-34,000
-46% -$1.71M 0.03% 485
2018
Q1
$2.32M Sell
74,000
-15,000
-17% -$469K 0.04% 449
2017
Q4
$3.04M Sell
89,000
-10,000
-10% -$342K 0.05% 374
2017
Q3
$3.18M Hold
99,000
0.06% 366
2017
Q2
$3.22M Buy
99,000
+4,000
+4% +$130K 0.06% 361
2017
Q1
$2.99M Buy
95,000
+8,000
+9% +$252K 0.06% 366
2016
Q4
$2.56M Buy
87,000
+8,000
+10% +$235K 0.06% 321
2016
Q3
$2.29M Buy
79,000
+16,000
+25% +$463K 0.06% 334
2016
Q2
$1.63M Sell
63,000
-37,000
-37% -$958K 0.04% 346
2016
Q1
$2.46M Sell
100,000
-28,000
-22% -$690K 0.06% 292
2015
Q4
$4.51M Sell
128,000
-46,400
-27% -$1.63M 0.12% 192
2015
Q3
$3.69M Sell
174,400
-9,600
-5% -$203K 0.09% 245
2015
Q2
$5.11M Buy
184,000
+73,000
+66% +$2.03M 0.11% 237
2015
Q1
$3.39M Sell
111,000
-9,000
-8% -$275K 0.07% 316
2014
Q4
$3.84M Buy
+120,000
New +$3.84M 0.08% 280